Giant Biogene Holding Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	4,564	2,504	1,331	7,103	367.81	72.32
Short-Term Investments	-	11.03	21.31	4.88	2.41	6.04
Trading Asset Securities	1,500	1,275	865.97	155.61	1,588	746.62
Cash & Short-Term Investments	6,064	3,790	2,218	7,263	1,959	824.99
Cash Growth	118.05%	70.85%	-69.46%	270.86%	137.40%	-
Accounts Receivable	195.92	102.03	69.42	65.64	54.52	138.57
Other Receivables	-	14.55	4.6	6.7	201.31	-
Receivables	195.92	116.57	74.02	72.34	255.83	572.16
Inventory	333.74	200.44	183.9	89.39	64.66	50.86
Other Current Assets	94.47	28.26	61.58	16.11	5.06	10.25
Total Current Assets	6,688	4,135	2,538	7,441	2,284	1,458
Property, Plant & Equipment	975.54	711.62	551.65	333.53	280.71	299.94
Other Intangible Assets	6.57	7.36	6.75	7.6	8.78	9.15
Long-Term Deferred Tax Assets	0.16	1.11	1.19	1.35	1.23	4.26
Other Long-Term Assets	99.91	117.91	40.9	94.41	76.28	25.33
Total Assets	7,781	4,973	3,138	7,878	2,651	1,797
Accounts Payable	337.11	133.11	54.65	23.61	31.95	22.78
Accrued Expenses	-	40.72	28.5	28.93	40.51	27.96
Current Portion of Leases	1.37	1.56	0.88	-	-	-
Current Income Taxes Payable	97.67	116.72	75.02	71.36	144.23	122.87
Current Unearned Revenue	54.27	37.25	13.95	17.78	3.85	5.67
Other Current Liabilities	1,265	201.25	107.9	6,701	1,953	446.78
Total Current Liabilities	1,756	530.61	280.91	6,843	2,174	626.05
Long-Term Leases	0.09	1.17	1.71	-	-	-
Long-Term Unearned Revenue	18.86	19.58	18.18	17.58	17.97	19.42
Long-Term Deferred Tax Liabilities	31.2	50.68	0.4	0.77	1.24	0.01
Total Liabilities	1,806	602.03	301.19	6,861	2,193	645.49
Common Stock	0.07	0.06	0.06	0.06	-	-
Additional Paid-In Capital	3,180	1,695	1,597	7,160	-	-
Retained Earnings	2,693	2,619	1,167	164.8	-	-
Treasury Stock	-0	-0	-0	-0	-	-
Comprensive Income & Other	96.44	48.81	69.72	-6,308	458	1,148
Total Common Equity	5,970	4,362	2,833	1,017	458	1,148
Minority Interest	4.72	8.91	3.56	-	-	3.75
Shareholders' Equity	5,975	4,371	2,837	1,017	458	1,151
Total Liabilities & Equity	7,781	4,973	3,138	7,878	2,651	1,797
Total Debt	1.46	2.73	2.59	-	-	-
Net Cash (Debt)	6,063	3,787	2,216	7,263	1,959	824.99
Net Cash Growth	118.16%	70.92%	-69.50%	270.86%	137.40%	-
Net Cash Per Share	6.15	3.85	2.17	7.26	1.96	0.82
Filing Date Shares Outstanding	1,009	976	976	900	1,000	1,000
Total Common Shares Outstanding	1,009	976	976	900	1,000	1,000
Working Capital	4,933	3,604	2,257	598.28	110.21	832.2
Book Value Per Share	5.92	4.47	2.90	1.13	0.46	1.15
Tangible Book Value	5,964	4,355	2,827	1,009	449.22	1,139
Tangible Book Value Per Share	5.91	4.46	2.90	1.12	0.45	1.14
Buildings	-	285.49	225.79	184.61	171.54	199.07
Machinery	-	131.75	104.62	69.28	59.51	56.32
Construction In Progress	-	356.25	244.44	81.58	50.89	30.82
Leasehold Improvements	-	9.54	5.56	1.86	1.86	-

Source: S&P Capital IQ. Standard template. Financial Sources.